Quantitative comparison of the efficacies and safety profiles of three first-line non-platinum chemotherapy regimens for advanced non-small cell lung cancer.

Yang, Qian-Yu; Zhu, Lin; Liu, Hong-Xia; Zheng, Qing-Shan; Li, Lu-Jin

Yang, Qian-Yu; Zhu, Lin; Liu, Hong-Xia; Zheng, Qing-Shan; Li, Lu-Jin.

Afiliação

Yang QY; Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhu L; Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Liu HX; Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zheng QS; Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li LJ; Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Front Pharmacol ; 13: 806728, 2022.

Article em En | MEDLINE | ID: mdl-36105225

Palavras-chave

NSCLC; ORR; OS; influencing factors; non-platinum chemotherapy; safety

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google